PUBLISHER: The Business Research Company | PRODUCT CODE: 1669748
PUBLISHER: The Business Research Company | PRODUCT CODE: 1669748
Kaempferol is a yellow, crystalline flavonol compound found in plants, either in its free form or in conjunction with glycosidic compounds. It exhibits properties that aid in treating hormone-affected malignancies such as leukemia, ovarian, breast, cervical, hepatocellular, and ovarian cancers.
The kaempferol market is segmented based on its sources, including tea, fruits, vegetables, and medicinal plants. Within this segmentation, vegetables encompass a variety of edible plant parts-fruits, seeds, roots, tubers, bulbs, stems, leaves, or flowers-used for kaempferol extraction. This compound shows potential as a chemopreventive agent against cancer. Purity levels for kaempferol range from 10%, 20%, 50%, 95%, to 98%. Its applications span across diverse industries such as food and beverages, cosmetics, pharmaceuticals, dietary supplements, and more.
The kaempferol market research report is one of a series of new reports from The Business Research Company that provides kaempferol market statistics, including kaempferol industry global market size, regional shares, competitors with a kaempferol market share, detailed kaempferol market segments, market trends, and opportunities, and any further data you may need to thrive in the kaempferol industry. This kaempferol market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The kaempferol market size has grown strongly in recent years. It will grow from $4.14 billion in 2024 to $4.35 billion in 2025 at a compound annual growth rate (CAGR) of 5.1%. The growth in the historic period can be attributed to plant-based nutrition research, biomedical and pharmacological studies, increased focus on antioxidants, biotechnological advancements, and botanical and phytochemical studies
The kaempferol market size is expected to see steady growth in the next few years. It will grow to $5.24 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to health and wellness trends, increased focus on antimicrobial properties, genetic modification for enhanced production, healthcare shift towards preventive measures, and rise in personalized medicine. Major trends in the forecast period include kaempferol for cardiovascular health, kaempferol in sports nutrition, biofortification of crops for higher kaempferol content, increased research in neuroprotective effect, and kaempferol-fortified functional beverages.
The kaempferol market is anticipated to experience growth, propelled by the increasing prevalence of cancer. Cancer, a group of diseases characterized by the uncontrolled growth of abnormal cells that can invade surrounding tissues and potentially spread to other parts of the body, has led to a rising demand for kaempferol. Kaempferol, a phytoestrogen found in plants, exhibits anti-cancer properties by inducing apoptosis, arresting the cell cycle, and inhibiting processes such as blood vessel development, migration, and invasion of cancer cells. As reported in April 2022 by the American Cancer Society, there were 1.92 million new cancer cases in the U.S., showing an increase from 1.89 million cases in 2021. Consequently, the growing prevalence of cancer is a significant factor driving the growth of the kaempferol market.
The expansion of the food and beverage industry is anticipated to fuel the growth of the kaempferol market. The food and beverage industry, encompassing the production, processing, distribution, and sale of food and drink products, plays a pivotal role in the utilization of kaempferol. This natural bioactive compound is sought after for its antioxidant properties, prompting its incorporation into various products within the industry. Kaempferol is commonly used in functional foods, beverages, and dietary supplements to enhance nutritional profiles and meet consumer preferences for health-promoting ingredients. In 2023, the Food & Drink Federation reported a 31% increase in food and drink exports in 2022 compared to the previous year. Furthermore, the industry contributed significantly to the economy, with a turnover of $3.52 billion (£10.3 billion) in 2022, accounting for 33% of total Scottish manufacturing. The expanding footprint of the food and beverage industry is a major driver for the kaempferol market, as its applications continue to diversify within the sector.
The growing expansion of the cosmetics industry is expected to drive the growth of the kaempferol market in the future. The cosmetics industry encompasses the production, distribution, and sale of products aimed at personal care and beautification. Kaempferol is used in cosmetics due to its antioxidant properties and potential skin health benefits. Its anti-inflammatory and anti-aging qualities make it a desirable ingredient, commonly added to skincare products to enhance skin wellness and offer protection against environmental stressors. For example, in July 2022, the Canadian cosmetics industry generated around $1.24 billion in 2021, with industry revenue projected to rise by 1.45% annually, reaching $1.8 billion by 2024. Consequently, the expanding cosmetics industry is fueling the growth of the kaempferol market.
Product innovations are emerging as a prominent trend in the kaempferol industry, with major companies actively developing innovative products to maintain their market positions. Conagen, a leading biotechnology company based in the United States, exemplifies this trend with its January 2022 announcement. The company successfully developed antioxidant kaempferol through state-of-the-art, proprietary precision fermentation. Precision fermentation is highlighted for its effectiveness and environmental friendliness compared to alternative methods such as chemical synthesis or botanical sourcing for flavonoids such as kaempferol. Conagen's innovative approach enables brands in the nutrition, cosmetics, and personal care sectors to adopt a more natural stance by incorporating their kaempferol in formulations. This emphasis on innovation underscores the dynamic landscape of the kaempferol market, with companies actively pursuing advancements to meet evolving industry demands.
In December 2023, Danaher Corporation, a US-based manufacturer of medical products, acquired Abcam plc for $5.7 billion. This acquisition aims to bolster Danaher Corporation's position in the life sciences sector by incorporating Abcam's expertise in supplying high-quality biological reagents and tools, thereby enhancing its portfolio of innovative medical and research products. Abcam plc, a UK-based company, specializes in the production of biopharmaceuticals, including kaempferol.
Major companies operating in the kaempferol market include Fujifilm Wako Pure Chemical Corporation, Merk Millipore, LGC Group, Abcam plc, ChromaDex Corporation, Cayman Chemical Company, BioVision Inc., Clearsynth Labs Ltd., Enzo Life Sciences Inc., Santa Cruz Biotechnology Inc., AppliChem GmbH, Conagen Inc., MedChemExpress LLC, BioBioPha Co. Ltd., FoodChem International Corporation, Oakwood Products Inc., Spectrum Chemical Mfg. Corp., Aktin Chemicals Inc., BOC Sciences, AK Scientific Inc., Chemfaces Biochemical Co. Ltd, INDOFINE Chemical Company Inc., Risun Bio-Tech Inc., Shaanxi NHK Technology, TCI Chemicals (India) Pvt. Ltd.
North America was the largest region in the kaempferol market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kaempferol market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the kaempferol market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
The kaempferol market consists of sales of luteolin, apigenin, flavanol, polyphenol, and glycoside. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Kaempferol Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on kaempferol market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for kaempferol ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kaempferol market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.